lOMoARcPSD|30126890

Must know - Summary in Hematology

BS in Medical Laboratory Science (Central Philippine University)

Studocu is not sponsored or endorsed by any college or university

Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

MUST TO KNOW IN HEMATOLOGY

Hematology Greek:
-Haima = Blood
-Logos = Study/science
EDTA Chelates calcium
(Lavender top) Inversion: 8x
Anticoagulant of choice for hematology cell counts and cell morphology
Blood smear: prepare w/in 2 hrs
Preferred anticoagulant for platelet count:
= In some patients w/ EDTA anticoagulated blood platelet satellitism
= Platelet satellitism: platelets adhere to neutrophils
Effect to automated platelet count Decreased
Remedy: Repeat platelet count using citrate (Rodak: Platelet count x 1.1)
EDTA = Shrinkage of cells = Hct = ESR
Not for coagulation tests:
= Inhibits fibrinogen-thrombin reaction
= Factor V is not stable in EDTA
Modified Westergren ESR 2mL EDTA + 0.5mL NSS/Citrate
(Black top tube) Ratio = 1:4 (Anticoagulant-to-Blood)
Citrate For coagulation and platelet studies
(Light blue top tube) = Preserves labile factors V and VIII
= Buffered 3.2% (0.109M) citrate
Inversion: 3-4x
Ratio = 1:9 (Anticoagulant-to-Blood)
Polycythemic patients Hct
Excess Citrate = PT, APTT
Remedy: Reduce the volume of citrate
Amount of citrate = [(100-Hct)÷(595-Hct)] x mL WB
Oxalate Double/balanced oxalate (Ratio = 2:3): Maintained cell structures
a. Potassium oxalate (Paul-
b. Ammonium
Heparin Inactivation of thrombin
Anticoagulant for osmotic fragility test
Inversion: 3-4x
Not for blood film preparation:
= Distorts cells

Not for coagulation

= Inhibits thrombin and all stages of coagulation
Order of Draw Evacuated tube:
(Henry 21st Edition) 1. Sterile blood culture tube
2. Citrate (blue)
3. Nonadditive tube (red)
4. Heparin (green)
5. EDTA (lavender)
6. Fluoride (gray)
Order of Draw 1. EDTA
(Syringe method) 2. Other anticoagulated tubes
3. Nonadditive tube
EDTA containing tubes Lavender

Page | 1
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Pink
White
Royal blue
Tan
Skin puncture 1. Fingertips
2. Earlobe: less admixture w/ tissue juice, less pain, less free nerve endings
3. Lateral portion of the plantar surface of the foot: <1 year old
Difference from venous specimen:
WBCs
Hgb, Hct, RBCs, platelet
Venipuncture Veins in the arms (antecubital region):
1. Median cubital = preferred, most stable
2. Cephalic (lateral)
3. Basilic (medial)
Common gauge (needle) 19, 20, 21
Routine: 20g
Common length of needle 1-1.5 inches
Color coded hub (gauge) 18 = pink
21 = green
22 = gray
23 = blue/light blue/turquoise
Angle Venipuncture: 150
BB: 450 10-200 once in the skin
Tourniquet 3-4 inches above the site (7.5-10cm)
Not exceed 1min/2mins
Prolonged application hemoconcentration
BP cuff as tourniquet 40-60 mmHg
Reassure the patient Crying = cell count
Position the patient Lying down = hemodilution ( PCV by 8%, WBC)
Lying up = hemoconcentration
IV line Collect on the other arm
If both arms: Stop IV for 2mins
= Collect blood below the IV line
= Appropriate for all analytes except glucose and phosphorus
Hematopoiesis Cellular formation, proliferation, differentiation and maturation of blood cells
Mesoblastic period 19th day of gestation
Yolk salk = Erythropoiesis
Embryonic hemoglobins:
a. Gower 1 = Zeta2 + Epsilon2
b. Portland = Zeta2 + Gamma2
c. Gower 2 = Alpha2 + Epsilon2
Hepatic period 3rd month of gestation
Fetal liver = Granulopoiesis, Erythropoiesis, Megakaryopoiesis
Spleen, thymus, lymph nodes
Hemoglobin production:
a. HbF = Alpha2 + Gamma2
b. HbA1 = Alpha2 + Beta2
c. HbA2 = Alpha2 + Gamma2
Myeloid period Between 5th & 6th month of gestation persist throughout life

Page | 2
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Sternum = principal source of hematopoiesis in adults

Adults HbA1
HbA2 = 1.5-3%
HbF = <2%
Neonates HbF = 60-80%
HbA = 20-40%
Marrow specimens 1. Trephine (Core) Biopsy
= Trephine biopsy needle (Jamshidi needle)
2. Aspiration
= Aspiration needle (University of Illinois sterna needle)
Posterior iliac creast Safest site for BM aspirate/biopsy
M:E ratio Numeric expression comparing the relative number of granulocytic precursors w/
the relative erythroid precursors in the BM
NV = 2:1 to 4:1 (Ave. 3:1)
Infection = 6:1
Leukemia = 25:1
Neutrophilic, Eosinophilic, Basophilic precursors = Myeloid
Erythroid precursors
Monocytic precursors = not included
BM Cellularity Percentage of marrow space occupied by hematopoietic cells compared w/ fat
Normocellular marrow (Adult):
Fat = 10-50%
Hematopoietic elements = 40-60% (Ave. 50%)
Yellow BM Fats
Red BM Hematopoietic cells
Marrow differential Recommended that at least 500, preferably 1000 cells be counted for a marrow
differential
Metamyelocyte/Juvenile Predominant cell (WBC) in adult BM (up to 32%)
granulocyte
Stem cells <1% cells in BM
Osteoblasts Bone forming cells
Confused w/ plasma cells
Waterbug or comet appearance
Osteoclasts Bone destroying cells
Confused w/ megakaryocytes
CD2, CD3 T cells
CD19, CD20 B cells
CD34 Stem cell marker (lymphoid and myeloid precursor)
CD16, CD56 NK cells
CD10 CALLA (Common ALL Antigen)
Erythropoietin Produced by the kidney
Primary regulator of erythropoiesis
Thrombopoietin Produced by kidney and liver
Regulator of thrombopoiesis
Erythropoiesis
IL-3 Multi-CSF (Colony Stimulating Factor)
Stimulates hematopoietic cells
1. Pronormoblast Proerythroblast/rubriblast
N/C ratio = 8:1
Nucleoli = 1-2
Page | 3
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Can produce up to 16 RBCs per 1 pronormoblast/rubriblast

2. Basophilic normoblast Prorubricyte
Intensely basophilic cytoplasm
N/C ratio = 6:1
Nucleoli usually not visible

3. Polychromatophilic Rubricyte
normoblast Blue-gray to pink-gray cytoplasm
Last stage capable of mitosis
1st: Hgb synthesis (1st: PCPNB Reticulocyte: Last)
N/C ratio = 4:1
4. Orthochromic normoblast Metarubricyte
Small pyknotic nucleus (dark, small, nonfunctional)
N/C ratio = 1:2
5. Reticulocyte Polychromatophilic erythrocyte/Diffusely basophilic erythrocyte
Romanowsky stain = Polychromasia
Supravital stain = (+) Fine reticulum of RNA
6. Mature RBC Discocyte
6-
Life span: 120 days
3-5 days BM: Pronormoblast Reticulocyte
1-2 days PB: Reticulocyte RBC
General Cell Maturation Characteristics for Leukocytes
Immature Cells Mature Cells
Larger Smaller
(+) Nucleoli (-) Nucleoli
Chromatin: fine and delicate (most reliable) Chromatin: coarse and clumped (most reliable)
Nucleus: large and round Nucleus: round. lobulated or segmented
Cytoplasm: dark blue/basophilic (RNA) Cytoplasm: light blue (RNA)
(-) Granules (+) Granules
N:C ratio N:C ratio
Granulopoiesis Neutrophils
Eosinophils
Basophils
14 days Blast Mature granulocyte
1. Myeloblast Earliest recognizable stage in granulocytic series
N/C ratio = 4:1
Nucleoli = 2-5
2. Promyelocyte 1st: Primary granules
N/C ratio = 2:1 to 3:1
Nucleoli = 2-3
3. Myelocyte Youngest cell in the series wherein a granulocyte can be identified
a. Neutrophil myelocyte = rose pink granules
b. Eosinophil myelocyte = orange-red granules
c. Basophil myelocyte = dark purple or blue-black granules
Last stage capable of mitosis
1st: Secondary granules
N/C ratio = 1:1
(-) Nucleoli
4. Metamyelocyte Juvenile granulocyte
Page | 4
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Not capable of mitosis (post-mitotic pool)

Indented/kidney-shaped nucleus
Predominant WBC in BM
5. Band Stab/Staff
Youngest cell in the series present in the peripheral blood (normal)
PB = 0-6% or 0-7%
C or S shaped nucleus
Curved or Sausage shaped nucleus
Resembles Pelger-Huet cells
= PH cells: coarser chromatin than stab cells
6a. Segmented neutrophil Rose-pink granules
Nucleus: 2-5 lobes
Diurnal variation (PM)
Specific granules:
a. Lysozyme
b. Lactoferrin
c. Collagenase
d. Plasminogen activator
e. Aminopeptidase
6b. Eosinophil Reddish-orange granules
Nucleus: usually 2 lobes
Diurnal variation (ACTH)
Specific granules:
[Larger]
a. Major basic protein
b. Acid hydrolase
c. Cathepsin
d. Eosinophil cationic protein
d. Eosinophil-derived neurotoxin
e. Eosinophil protein X
f. Phospholipase
[Smaller]
a. Arylsulfatase
b. Acid phosphatase
6c. Basophil Dark purple to blue-black granules (water-soluble)
Nucleus: generally unsegmented or bilobed (rare: 3 or 4)
Specific granules:
a. Histamine
b. Heparin
c. Eosinophilic chemotactic factor A
Monopoiesis 1. Monoblast
2. Promonocyte
3. Monocyte
Monocyte Largest cell in PB
14-
Blue-gray cytoplasm
Many azurophilic granules (ground glass appearance)
Nucleus: kidney/horse-shoe shaped, may be folded (brainlike)
Lymphopoiesis 1. Lymphoblast
2. Prolymphocyte

Page | 5
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

3. Lymphocyte
Lymphocyte Small = 8-
Medium = 10-
Large = 12- (Rare)

Nucleus: compact
T lymphocytes 60-80%
Long-lived (4-10 years)
B lymphocytes 10-20%
Short-lived (3-4 days)
Can differentiate into plasma cell or memory B cells
Null lymphocytes Large granular lymphocyte
10%
Plasma cells differentiation 1. Plasmablast
2. Proplasmacyte
3. Plasmacyte/Plasma cell
Plasma cell Large well-defined hof/perinuclear halo (light staining area in the cytoplasm near
the nucleus)
Eccentric nucleus
Deeply basophilic cytoplasm (Red/pink cytoplasm: Flame cell [Abnormal])

Thrombopoiesis 5 days (Megakaryoblast Platelets)

1. Megakaryoblast N/C ratio = 10:1
2. Promegakaryocyte Nucleus: may show slight lobulation (Endomitosis)
N/C ratio = 4:1 to 7:1
3. Granular megakaryocyte
4. Mature megakaryocyte Largest cell in BM
Cytoplasm contains coarse clumps of granules aggregating into little bundles, which
bud off from the periphery to become platelets
Multiple nuclei
N/C ratio = <1:1
5. Metamegakaryocyte Disintegrated cell surrounded by platelet
6. Platelet/Thrombocyte 1-
Light blue to purple
Very granular
a. Chromomere: granular and centrally located
b. Hyalomere: surrounds the chromomere, nongranular and clear to light blue
Life span: 8-11 days
2/3 (67%) Circulating platelets
1/3 (33%) Platelets stored in the spleen
Endomitosis Nuclear division w/o cytoplasmic division
2000-4000 # of platelets a megakaryocyte can produce
1 heme molecule 1 mol O2
1 hemoglobin 4 mol O2
Mitochondria Early and late heme synthesis
141 amino acids Alpha
146 amino acids Beta, Gamma, Delta, Epsilon, Zeta
Chromosome 11 Alpha, Zeta
Chromosome 16 Beta, Gamma, Delta, Epsilon
Oxyhemoglobin Dissociation Normal = Sigmoid in shape
Page | 6
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Curve X-axis = Hgb concentration in g/dL | Y-axis = OD

Shift to the left (ODC) CO2
Temperature
2,3-DPG
pH
Affinity of Hgb for O2
HbF
Shift to the right (ODC) CO2
Temperature
2,3-DPG
pH
Affinity of Hgb for O2

Heme synthesis Succinyl coenzyme A + Glycine + Pyridoxal PO4

(ALA synthase)

D-Aminolevulinic acid

(ALA dehydrase)

Porphobilinogen

(Uroporphyrinogen synthase)
(Uroporphyrinogen cosynthase)

Uroporphyrinogen

(Uroporphyrinogen decarboxylase)

Coproporphyrinogen

(Coproporphyrinogen oxidase)

Protoporphyrinogen

(Protoporphyrinogen oxidase)

Protoporphyrin IX + Fe2+

(Ferrocheletase)

HEME
Arterial blood O2 saturation = 95%
pO2 = 95 mmHg
Venous blood O2 saturation = 70%
pO2 = 40 mmHg
P50 pO2 = 26.6 mmHg
Bohr effect pH = Hgb affinity for O2 --- (L)
pH = Hgb affinity for O2 --- (R)
Oxyhemoglobin (HbO2) Arterial blood

Page | 7
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Blood: Bright red color

Deoxyhemoglobin (HbCO2) Venous blood
Blood: Purplish red color
Carboxyhemoglobin (HbCO) Blood: Cherry red color
Reversible
Cannot bind and carry O2
CO has 200x or 210x greater affinity for Hgb compared to O2
Smoking, gas, etc.
Methemoglobin/ Hemiglobin Blood: Chocolate brown color
(Hi) Reversible
Fe2+ Fe3+
Methemoglobin reductase deficiency
Exposure to chemicals/drugs
Exposure to nitrite, chlorine and nitrate
HbM (Abnormal hemoglobin)
Sulfhemoglobin Blood: Mauve lavender
Irreversible
Cannot transport O2
Can combine w/ CO forming carboxysulfhemoglobin
Mixture of oxidized, partially denatured forms of hemoglobin that form during
oxidative hemolysis green hemochrome
Sulfonamides, aromatic amine drugs
Bacteremia: Clostridium perfringens
Enterogenous cyanosis
Erythrocyte membrane 50% protein:
1. Integral protein: Glycophorin A
= Contains sialic acid: (-) charge
= Zeta potential: red cells repel each other
2. Peripheral protein: Spectrin and Actin
= Responsible for biconcave shape of red cells
= Abn. Spectrin: Hereditary Spherocytosis, Hereditary Elliptocytosis
40% lipid:
1. Phospholipids
2. Cholesterol = LCAT
10% CHO
Embden-Meyerhoff pathway Major pathway
90% glycolysis (anaerobic)
Glucose Lactic acid = 2 ATP
PK deficiency: common enzyme deficiency
Hexose monophosphate 10% glycolysis (aerobic)
shunt Provides reduced glutathione to prevent Hgb denaturation
(Pentose PO4 pathway) G6PD deficiency: most common red cell enzyme deficiency
= (+) Heinz bodies: denatured Hgb (Supravital stain: RHH)
= (+) Bite cells: due to pitting
Rapoport-Luebering pathway Generates 2,3-DPG that regulates Hgb affinity for O2
Methemoglobin reductase Maintains Hgb iron in ferrous (Fe2+) state to be functional
pathway
Pitting Removal of inclusion by the spleen
Culling Removal of senescent/aged RBCs by the spleen
RBC lysis RBC age = Enzymes, ATP, Size, Density

Page | 8
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

1% of RBCs/day broken down by the mononuclear phagocytic system (MPS)

Extravascular hemolysis 90% aged red cell destruction
w/in the RES

Unconjugated bilirubin
Urine and fecal urobilinogen
Intravascular hemolysis 10% aged red cell destruction
w/in the blood vessels

Haptoglobin
Hemopexin
(+) Hemoglobinemia
Anisocytosis Variation in size
RDW Numerical expression that correlates w/ the degree of anisocytosis
NV = 11.5-14.5%
Anisochromia Variation in Hgb content (Ex. Dimorphic anemia)
MCV NV = 80-100fL (Normocytic)
<80fL = Microcytic
>100fL = Macrocytic
MCH NV = 27-32 pg
MCHC NV = 31-36% (Normochromic)
<31% = Hypochromic
>36% = Hyperchromic
Normocytic normochromic 1. Acute blood loss
anemia 2. Hemolytic anemia
3. Aplastic anemia
Microcytic hypochromic 1. Chronic blood loss = most common cause
anemia 2. Thalassemia = N-RDW
3. IDA = Iron, TIBC (Ex. Hookworm infections) | RDW
4. Sideroblastic anemia
5. Chronic disease
Macrocytic, normochromic 1. Megaloblastic anemia = Vitamin B12/Folate deficiency
anemia 2. Nonmegaloblastic anemia = Liver disease, alcoholism
Aplastic anemia
Acquired = radiation, chemical (benzene), drugs (chloramphenicol)
Pancytopenia = WBCs, RBCs, Retics Plts
TIBC Differentiates IDA (TIBC) from other microcytic, hypochromic anemia
Degree of Hypochromia Normal = Area of palor 1/3 of the cell diameter
1+ = Area of palor 1/2 of the cell diameter
2+ = Area of palor 2/3 of the cell diameter
3+ = Area of palor 3/4 of the cell diameter
4+ = Thin rim of hemoglobin
Megaloblastic anemia Oval macrocytes
Howell-Jolly bodies
Hypersegmented neutrophils
Ineffective erythropoiesis (pancytopenia)
Vitamin B12 (Cobalamin) w/ CNS problems
deficiency 1. Pernicious anemia
= Deficient in intrinsic factor (produced by parietal cells) for B12 absorption
2. D. latum infection

Page | 9
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Folic acid (Vit. B9) deficiency
Polychromasia
3. Vegetarian diet
4. Malabsorption syndrome
= Steatorrhea, sprue
w/o CNS problems
1. Pregnancy
2. Dietary deficiency
3. Steatorrhea, sprue
Reticulocytosis

Blue-gray coloration, pink cytoplasm

Indicates young RBCs
Erythropoietic activity
a. Hemorrhage
b. Hemolysis
Spherocytosis EOFT
Microcytic, hypochromic EOFT

Poikilocytosis Variation in shape

ESR = No rouleaux formation
Macrocytes Megalocytes: Vit. B12 or folic acid deficiency
Oval macrocytes Asynchronous development: mature cytoplasm but immature nucleus
Macroovalocytes
Acanthocyte Irregular spikes/spicules
Spur cell Abnormal L:S ratio
Thorn cell Abetalipoproteinemia
Liver diseases
Echinocyte Echinocyte: artifactual
Burr cell Burr cell: pathologic
Sea urchin cell RBCs w/ projections of equal length and distribution
Crenated RBCs ATP
Exposure to hypertonic solution
Artifact in air drying
Anemia associated w/ renal insufficiency
Codocyte Greek: Kodon = bell
Target cell Cen
Mexican hat cell Scanning EM: Bell/tall hat shaped
Surface membrane to volume ratio
Cholesterol & phospholipid
Hemoglobinopathies
Thalassemia
Liver disease, postsplenectomy, IDA
Leptocyte Thin variant of a codocyte
Spherocyte Spheroid
Ball Biconvex
Bronze cell Surface area to volume ratio
Defect of loss of membrane:
Hereditary spherocytosis = Post-splenectomy: Spherocytes
Hemolytic anemia
Burns
Banked blood stored for a long time

Page | 10
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

AIHA vs. HS AIHA = OFT, MCHC, (+) DAT

HS = OFT, MCHC, (-) DAT
Stomatocyte Greek: Stoma = mouth
Mouth, slit-like pallor area
Bowl-shaped
Permeability to Na+ (Normal: permeability to K+)
Hereditary stomatocytosis
Rhnull disease
Elliptocyte Rod/cigar shaped
Narrower than ovalocytes
Defect in cytoskeleton
Membrane protein band 4.1
Ovalocyte Egglike/oval-shaped
Wider than elliptocytes
Bipolar arrangement in Hgb
Cholesterol
Hereditary ovalocytosis
Megaloblastic BM
Myelodysplasia

Schistocyte Fragmentation produced by damage of RBC by fibrin, altered vessel walls,

Schizocyte prosthetic heart valves
Fragmentocyte Microangiopathic hemolytic anemia
-
Burns
TTP
DIC
Keratocyte Schistocyte w/ hornlike projections
Knizocytes Triangular cells
Pinch cells 2 palor areas
Dacryocyte Teardrop/pear-shaped
Teardrops Squeezing and fragmentation during splenic passage
MMM
Hypersplenism
Microspherocyte Severe burns
Pyropoikilocyte Hereditary microspherocytosis
Hereditary pyropoikilocytosis
= sensitivity to temperature

Semilunar bodies Large, pale pink staining ghost of the red cell
Half-moon cell Membrane remaining after the contents have been released
Crescent cell Malaria
Burns Spherocytes
Schistocytes
Microspherocytes
Drepanocytes Crescent-shaped cell
Sickle cells Holly-leaf
Menisocytes Polymerization of deoxygenated Hgb
Sickle cell anemia
Page | 11
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Sickle cell disease

Howell-Jolly bodies Nuclear remnants of DNA (from karyorrhexis)
Feulgen (+)
Megaloblastic anemia
Basophilic stippling Precipitation of ribosomes and RNA
Punctate basophilia 1. Fine stippling = polychromatophilia ( production of RBCs)
2. Course stippling = Lead poisoning
Pyrimidine-5-nucleotidase deficiency = Basophilic stippling
PICA In children = Lead poisoning
In adults = IDA
Cabot rings Figure of 8
Remnant of microtubules of mitotic spindle
Megaloblastic anemia
Heinz bodies Precipitated, denatured Hgb
Multiple Heinz bodies Pitted golf ball appearance
Requires Supravital stain (RHH)
G6PD deficiency
Unstable hemoglobins (HbH)
Favism (Fava beans)
Drug-induced
Acetylphenylhydrazine/phenylhydrazine = Induce Heinz bodies formation
HbH inclusions Tet 4)
Requires Supravital stain (RHH)
HbCC crystals Bar of Gold
Clam shell appearance
Hexagonal w/ blunt ends and stain darkly
Solubility
HbSC crystals Washington monument shape
Dark-hued crystal of condensed Hgb distorts the RBC membrane
Solubility
Ringed Sideroblast Nucleated RBC (immature) that contains nonheme iron particles
Requires Prussian blue stain
Sideroblastic anemia (Iron overload)
MDS
Siderocyte Non-nucleated RBC (mature) containing iron granules (hemosiderin)
Sideroblastic anemia
MDS
Pappenheimer bodies
Resembles basophilic stippling
= PB: Periphery
= BS: Homogeneous
Unused iron deposits
Sideroblastic anemia
MDS
Malaria MOT: Anopheles mosquito bite
Maturation stages: Rings > Trophozoite > Schizonts > Gametocytes
P. vivax = Worldwide
P. falciparum = Philippines
Resistant to Malaria:
= Fy(a-b-): African

Page | 12
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

= Sickle cell anemia

= G6PD deficiency
Babesia MOT: Tick bite

Resemble P. falciparum rings

Agglutination Cold agglutinin disease (anti-I)
Primary atypical pneumonia (anti-I)
Rouleaux RBCs in stack of coins arrangement
plasma globulin
Multiple myeloma: proliferation of Ig-producing plasma cells (ESR)
Macroglobulinemia
Drop of NSS Disperses rouleaux formation
True agglutination remains intact
Hemoglobinopathies
Hemoglobinopathies Qualitative defect in Hgb
Ex. Substitution
6 Glu Val
HbS 2 2
6 Glu Lys
HbC 2 2
26 Glu Lys
HbE 2 2
Sickle cell anemia 80/90-100% HbS
HbF & HbA2
Sickle cell trait 55-60% HbA1 |40-45% HbS
Thalassemia
Thalassemia Quantitative defect in Hgb
-thalassemia Alpha-globin chain is or absent
4 = HbH (deletion of 3/4 alpha genes)
4
-thalassemia Beta-globin chain is or absent
HbF and HbA2
Thalassemia major
-thalassemia
Thalassemia minor
-thalassemia
Cellulose acetate Hgb Alkaline pH: 8.6
electrophoresis Migration: (Cathode > Anode)
C > S > F > A1 > Barts > I > H
E D
O G
A2 Lepore
Normal: HbA1 is the fastest (most anodal)
Abnormal: HbH is the fastest (most anodal)
Citrate agar Hgb Acid pH: 6.0-6.3
electrophoresis Migration: (Cathode > Anode)
F > A |Origin| O > S > C
E D
G
Screening test for HbS 1. Sodium metabisulfite = (+) Sickling of cells
2. Solubility test
= Sodium thiosulfite
= (+) Turbidity
Page | 13
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

HbA2 -thalassemia
Quantitation: Anion exchange microchromatography
HbF Alkali resistant
(+) HiCN
Tests:
1. Alkali denaturation test
= HbF resists alkali denaturation
a. Betke (NaOH)
b. Singer (KOH)
2. Acid elution test
= HbF resists acid-elution
= Cells w/ HbF = deep pink color
= Cells w/ N-HbF = ghost cells
Tests for unstable Hgb (HbH)
2. Isopropanol precipitation test: 17% solution
Sample Criteria for Erythrocyte Morphology Evaluation
Morphology Characteristics w/in Normal 1+ 2+ 3+ 4+
Limits (OIO) (per OIO) (per OIO) (per OIO) (per OIO)
0-5 5-10 10-20 20-50 >50
0-5 5-10 10-20 20-50 >50
Hypochromia 0-2 3-10 10-50 50-75 >75
Poikilocytosis 0-2 3-10 10-20 20-50 >50
Polychromatophilia -- 1-5 6-10 >10 --
Rouleaux -- Numerous --
Agg. of 3-4 RBCs Agg. of 5-10 RBCs
aggregates
Nuclear Abnormalities
Pelger-Huet Hyposegmentation (neutrophil)
Bilobed nucleus: Dumb-bell shaped/spectacle/peanut- -
Resembles Stab cell (To differentiate: PH cell has more clumped chromatin)
Pelger-Huet anomaly = Autosomal Dominant
Pseudo-Pelger-Huet = Acquired in myeloproliferative disorders
Hypersegmentation
Abnormal DNA synthesis
Undritz anomaly = hereditary hypersegmentation
Megaloblastic anemia
Cytoplasmic Abnormalities
Alder-Reilly granules Large purple-black coarse cytoplasmic granules
Accumulation of degraded mucopolysaccharides (all leukocytes)
Alder-Reilly anomaly = Autosomal Recessive
Mucopolysaccharidoses: Hurler, Hunter, Sanfilippo syndrome
Resemble toxic granules (IT)
Toxic granules Large purple to black granules resembling ALR granules
Infections
Toxic states
Toxic vacuoles Infections
Toxic states
Auer rods Pink or red rod shaped structures
Fused primary granules (peroxidase positive)
Myeloid and monocytic series only
Faggot cells w/ mass of Auer rods

Page | 14
Downloaded by Sheena Blones (shinafied@gmail.com)

Chediak-Higashi granules
May-Hegglin inclusion
Dohle bodies
Dohle-Amato bodies
IT: Infections, Toxic states
Lazy leukocyte syndrome
Chronic Granulomatous
Disease (CGD)
LE cell
Tart cell
Reactive lymphocyte
Atypical lymphocyte
Stimulated lymphocyte
Variant lymphocyte
Downey cell
Basket cell
Smudge cell
lOMoARcPSD|30126890
M3 (APL) = associated w/ DIC
Giant red, blue to grayish round inclusions (large lysosomal granules)
Seen in lymphocyte, neutrophil and monocyte
Lysosomal defects
Platelets lack dense granules
Chediak-Higashi syndrome = Autosomal Recessive (Albinism)
Pale blue inclusions derived from RNA
May-Hegglin anomaly
= Autosomal Recessive
= Giant platelets
= Thrombocytopenia
Resemble Dohle bodies (IT)
Single or multiple blue inclusions
Aggregates of free ribosomes of rough ER
Resembles
Infections
Toxic states
Dohle bodies
Toxic granules
Toxic vacuoles
Abnormalities in Function
Normal random activity
Abnormal chemotactic activity
Abnormal random and chemotactic activity
Inability of phagocytes to kill ingested microorganisms
Impaired NADPH oxidase
Impaired oxidative metabolism/respiratory burst
Test: NBT dye test
Cells Exhibiting Phagocytosis
Neutrophil w/ large purple homogeneous round inclusion
Believe to be a neutrophil that ingested another neutrophil
Buffy coat
Smooth and evenly stained
SLE
Monocyte w/ ingested lymphocyte
Rough and unevenly stained
Abnormalities Involving Lymphocytes
a. Type I
= Plasmacytoid lymphocyte w/ large block of chromatin
b. Type II
= Infectious mononucleosis: caused by EBV (target: B cells [CD21])
= Atypical lymphocyte in IM: T cells reacting to B cells infected w/ EBV
c. Type III
= Vacuolated
= Swiss cheese/moth eaten appearance
Lymphocyte w/ thumbprint appearance
Due to pressure in smear preparation
Automated cell count
Page | 15
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Remedy: Add bovine albumin

CLL
Hairy cells B cells w/ hair-like projection
Hairy cell leukemia = TRAP (+)
Sezary cells -
Sezary syndrome
Mycosis fungoides
Abnormalities Involving Monocytes/Macrophages/Histiocytes
(Lipidoses/Lipid Storage Diseases)
Accumulation of glucocerebroside
(- -glucosidase
Wrinkled/crumpled cytoplasm (Chicken scratch)
Niemann-Pick disease Accumulation of sphingomyelin
(-) sphingomyelinase
Foamy cytoplasm
Foam cells w/ sphingomyelin
Accumulation of glycolipid and ganglioside
(-) Hexosaminidase A
Vacuolated cytoplasm
Accumulation of glycolipid and ganglioside
(-) Hexosaminidase A & B
Vacuolated cytoplasm
Sea blue histiocytosis Unknown enzyme deficiency
Blue-green cytoplasm
Abnormalities Associated w/ Plasma Cells
Flame cell Plasma cell w/ red to pink cytoplasm
Multiple myeloma of IgA origin
Grape cell Plasma cell w/ vacuoles
Mott cell Accumulation of Russell bodies
Morula cell Multiple myeloma
Berry cell
Russell bodies Individual globules of immunoglobulin
Intranuclear protein inclusions
Platelet Abnormalities (Morphologic)
Giant platelet Bernard-Soulier syndrome
May-Hegglin anomaly
Small/micromegakaryocyte Myelodysplastic syndromes
Large megakaryocyte
Mononuclear megakaryocyte
Vacuolated megakaryocyte
Leukemia
Leukemia Abnormal, uncontrolled proliferation and accumulation of one or more of the
hematopoietic cells
Symptoms: Fever, weight loss, sweating; hepatosplenomegaly, enlarged lymph
nodes (chronic leukemia)
BMR
Acute leukemia Days to 6 months

Subacute leukemia 2 to 6 months

Chronic leukemia Variable
Page | 16
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Leukemic leukemia
Subleukemic leukemia
Aleukemic leukemia
French-American-British
(FAB) Classification of Acute
Leukemias
Acute leukemia
Minimum of 1 or 2 years
Predominantly mature cells
(+) Abnormal and immature cells in PB
(-) Abnormal and immature cells in PB
Divides acute leukemias into lymphoblastic and monoblastic
= Subdivided according to cellular morphology, cytochemical staining results,
cytogenetic studies and T & B lymphocytes marker results
Normocytic, normochromic RBCs

Acute leukemia in children 80% ALL

20% ANLL
Tests to differentiate ALL 1. MPO: Myeloperoxidase
from ANLL = (+) AML
= (-) ALL
2. SBB: Sudan Black B
= (+) AML
= (-) ALL
3. TdT: Terminal Deoxyribonucleotidyltransferase
= Marker for immature lymphocyte
= (+) ALL
= (-) ANLL
Acute Lymphoblastic Leukemias (ALL)
L1 Lymphoblasts are small and homogeneous (vary little in size)
Childhood ALL
L2 Lymphoblasts are large and heterogeneous (vary in size)
Adult ALL
L3 Burkitt-type
Rare
Lymphoblasts are large but homogeneous, and vacuolated
Acute Nonlymphocytic Leukemias (ANLL)
M1 Acute myeloblastic leukemia w/o maturation (AML w/o mat)
BM:
>30% blasts
<10% granulocytic cells
M2 Acute myeloblastic leukemia w/ maturation (AML w/ mat)
BM:
>30% blasts
>10% granulocytic cells
M3 Acute promyelocytic leukemia (APL)
>30% blasts
>10% granulocytic cells
>30% or >50% promyelocytes
(+) Faggot cells = Associated w/ DIC
M4 Acute myelomonocytic leukemia (AMML)

20% to <80% monocytic cells

Page | 17
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

M5a Acute monoblastic leukemia w/o maturation

>80% monocytic cells (>80% monoblasts)

M5b Acute monoblastic leukemia w/ maturation
>80% monocytic cells (<80% monoblasts)
M6 Erythroleukemia
Erythremic myelosis

M7
MPD
1. Chronic Myelogenous
Leukemia (CML)
2. Myelofibrosis w/ myeloid
metaplasia (MMM)
3. Essential
Thrombocythemia (ET)
4. Polycythemia Vera (PV)
appropriate production of
EPO
inappropriate production of
EPO
Relative polycythemia
>30% blasts
>50% erythrocytic precursors
Acute megakaryocytic leukemia
>30% blasts
>30% megakaryocytic cells
Chronic Myeloproliferative Disorders
Proliferation of abnormal pluripotential stem cell
Stem cell differentiates into the granulocytic (myeloid stem cell), megakaryocytic
and erythroid cell lines
(+) Philadelphia chromosome: t(9+;22-) - both long arms
If (-
Similar to leukomoid reaction, to differentiate:
a. Chromosome studies
b. LAP = ( in Leukomoid reaction, in CML)
Fibrosis and granulocytic hyperplasia of BM, w/ granulocytic and megakaryocytic
proliferation in the liver and spleen (extramedullary)
(+) Dacryocytes
LAP
BM aspirate = impossible (dry tap)
BM biopsy = appropriate
Thrombocytosis: 1,000 x 109/L
Functionally abnormal platelets
BM: Panmyelosis
PB: Pancytosis/Pancythemia
RBCs, WBCs, Plts
LAP (Other polycythemia: N-LAP)
Polycythemia
Other names: Polycythemia Vera, Polycythemia Rubravera, Vaquez Osler disease,
Panmyelosis
RBC mass ( Hct)
RBCs, WBCs, Platelets
Erythropoietin (EPO)
In response to hypoxia
In patients w/ pulmonary/cardiac disease
RBCs, WBCs, Platelets
EPO
In patients w/ tumors of kidney, liver, brain, adrenal and pituitary gland
RBCs, N-WBCs, N-Platelets
EPO
Spurious/Gaisböck polycythemia
Associated w/ stress and anxiety
N-RBC mass

Page | 18
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Hct because of decreased plasma volume

RBC mass Differentiate absolute from relative polycythemia
RBC mass = Absolute polycythemia
N-RBC mass = Relative polycythemia
Myelodysplastic Syndrome/Dysmyelopoietic Syndrome
MDS Clonal abnormalities in hematopoietic cells
-
<30% blast
Differentiation % Blasts in PB % Blasts in BM Comments
Refractory anemia Mildest type
<1% <5%
(RA)
RA w/ ringed sideroblast <5% RS: Ringed sideroblast
<1%
(RARS) >15% RS
RA w/ excess blast
<5% 5-20%
(RAEB)
RAEB in transformation
>5% 20-30%
(RAEBt)
Chronic Myelomonocytic Persistent monocytosis
<5% 5-20%
Leukemia (CMML)
Lymphoproliferative disorders
LPD Proliferation of cells derived from lymphoid stem cell T/B cells
1. T/B cell leukemia --
2. Lymphoma Malignancy involving lymphoid tissue
a. Non-
= proliferation of neoplastic lymphocytes
= Rappaport classification
lymphoma
= proliferation of cells reacting to neoplasm
= (+) Reed-
Diagnosis: Lymph node biopsy
= Rye classification: based on histologic appearance of lymph node biopsy
= Ann-Arbor: staging based on the extent of tissue involved
3. Hairy cell leukemia Leukemic reticuloendotheliosis
Originally B cells w/ hairlike projections
(+) TRAP: Tartrate-resistant acid phosphatase

4. Mycosis fungoides and Neoplastic T cells

Sezary syndrome Sezary cells: w/ cerebriform nucleus (Brainlike)
Special Stains
Myeloperoxidase (MPO) Marker for primary granules and Auer rods
(+) AML
(-) ALL
Stain should only be done on fresh specimens
Sudan Black B (SBB) Marker for phospholipids and lipids
(+) AML
(-) ALL
Can be done on stored specimens
Parallels MPO for interpretation
Terminal DNA polymerase immunoperoxidase
deoxyribonucleotidyl Marker for immature lymphocytes
Page | 19
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Transferase (TdT) (+) ALL

(-) AML
Periodic Acid-Schiff (PAS) Marker for glycogen, glycoproteins, mucoproteins and HMW CHO
a. Normal: all blood cells are PAS (+) except erythroblast
b. Abnormal: erythroblasts are PAS (+) = M6
(+) L1 and L2 = blocklike positivity
(-) L3
(+) M6
Naphthol AS-D Chloroacetate Specific esterase
esterase Marker for mature and immature neutrophils and mast cells
(+) AML
(-) AMoL [M5]
(-) ALL
Lasts for months
-Naphthyl Acetate esterase Nonspecific esterase
Marker for monocytes, megakaryocytes and plasma cells
(+) AMoL [M5] = inhibited by fluoride
(+) AMegL [M7]
(-) AML
-Naphthyl Butyrate esterase Nonspecific esterase
Identifies monocytes, promonocytes and monoblasts
(+) AMoL [M5] = inhibited by fluoride
(-) AML
Acid phosphatase Present in all hematopoietic cells and found in lysosomes
(+) Hairy cell leukemia = TRAP (+)
(+) T cell leukemia
(-) Non-T cell leukemia
Cannot be stored
Tartrate resistant acid Excellent marker for hairy cell leukemia
phosphatase (TRAP)
Leukocyte alkaline Neutrophil is the only leukocyte that contains this activity
phosphatase (LAP)/
Neutrophil ALP (NAP) Leukomoid reaction, MMM, PV, 3rd trimester of pregnancy
CML, CGL, PNH
Should be done on fresh specimen
Kaplow count:
= Count 100 neutrophils
= Grade 0 to 4+
NV = 30-185
LAP Score:
0 = No stain
1+ = Faint stain
2+ = Pale stain
3+ = Strong stain
4+ = Deep (Very intense) stain
Toluidine blue Binds w/ acid mucopolysaccharides in blood cells
Strongly metachromatic
Useful for recognition of mast cells and tissue basophils (metachromatic granules)
CGL: Chronic granulocytic leukemia
Cooper & Cruickshank Stain for basophils

Page | 20
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Reagent: Toluidine blue

Nitroblue tetrazolium test Test for CGD
(Original) NBT: Colorless to pale yellow ---(Toxic O2 molecules)---> (+) Blue formazan
Test:
Heparinized blood Centrifuge Buffy coat (WBC) + NBT (+) Formazan

CGD = 0 to negligible
Infection = 70%
Modified NBT w/ stimulating agent
Test:
Buffy coat (WBC) + Bacterial suspension ---(NBT)---> (+) Formazan
NV = 80-100% formazan
CGD = <50% formazan
Feulgen reaction Specific reaction for DNA
Howell-Jolly bodies = Feulgen (+)
Prussian blue stain Stain for hemosiderin
(+) Sideroblast
(+) Siderocytes
Supravital stain (RHH) RHH = NCB
Reticulum = New methylene blue
Heinz bodies = Crystal violet
Hemoglobin H = Brilliant cresyl blue
BCB Stain for automated cell counter

Page | 21
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

HEMOSTASIS
Primary hemostasis Involves blood vessels and platelets
Formation of platelet plug
Test: Bleeding time
Platelets Functions:
Adhesion
Activation
Release
Aggregation
Secondary hemostasis Involves the coagulation factors
Formation of stable fibrin clot
Test: Clotting time
Arteries Carry blood from the heart to the capillaries
Primary Hemostasis
Veins Return blood from the capillaries to the heart
Capillaries Injured vessel: vasoconstriction
= initiated by serotonin and thromboxane A2 derived from platelets and endothelial
cells
Maturation Stage Cytoplasmic Cytoplasmic Tags Nuclear Features Thrombocytes
Granules Visible
Megakaryoblast (-) (+) Single nucleus (-)
Fine chromatin
(+) Nucleoli
Promegakaryocytes Few (+) 2 nucleus (-)
Megakaryocytes Numerous Usually (-) 2 or more nuclei (-)
Metamegakaryocytes Aggregated (-) 4 or more nuclei (+)
Platelet structure 60% proteins
30% lipids
8% carbohydrate
Various minerals, water, nucleotides
1. Peripheral zone = responsible for adhesion and aggregation
a. Glycocalyx = outer surface
b. Plasma membrane = consists of 30 or more glycoprotein
c. Submembranous area
2. Sol-gel zone = platelet shape & contractile elements
a. Microfilaments: actin & myosin (actomyosin/thrombostenin)
= responsible for clot retraction
b. Microtubules = consists of tubulin: maintain the platelet shape
3. Organelle zone
= alpha & dense granules
= mitochondria, lysosomal granules
4. Membranous system
a. Dense tubular system = site of arachidonic acid metabolism
b. Open canalicular system (surface connecting system) = release of granules
Platelet Adhesion Platelet adherence to exposed subendothelial surface (collagen)
Occurs in the presence of von Willebrand factor
In vivo: collagen
In vitro: glass
Bernard-Soulier syndrome (-) gpIb = receptor for vWF
(Giant platelet syndrome)

Page | 22
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Von Willebrand disease (-) vWF = for platelet adhesion

Platelet Activation
TxA2
Aspirin
Platelet Secretion
Release disorders
Important Substances Secreted by Platelets & Their Role in Hemostasis
Promote coagulation
Morphologic and functional changes in platelets
Agonists: substance that initiate activation
Arachidonic acid ---(Cyclooxygenase)---> Thromboxane A2
Vasoconstrictor
Stimulate platelet secretion
Inhibits COX
bleeding time
Release of granules
a. Alpha granules
= Platelet factor
= Platelet derived growth factor
= Fibrinogen
= Factor V
= vWF
-thromboglobulin
= Thrombospondin
= Fibronectin
= Albumin
b. Dense granules (CAPAS)
= Calcium
= ADP
= Pyrophosphate
= ATP
= Serotonin
Storage pool defects:
a. Alpha-granule deficiency
Gray platelet syndrome
Quebec platelet disorder = (-) Factor V binding protein (multimerin)
b. Dense granule deficiencies
Hermansky-Pudlak
Chediak-Higashi
Wiskott- le deficiency)

Promote aggregation ADP (d)

Calcium (d)

Promote vasoconstriction Serotonin (d)

Thromboxane A2 precursors (mb.PL)
Promote vascular repair Platelet-
-
Other systems affected
2-

Platelet aggregation Platelet attachment to each other

Page | 23
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Requires fibrinogen and Ca2+

(-) gpIIb/IIIa complex: receptor for fibrinogen
Petechiae Pinpoint hemorrhagic spots
Purpura Hemorrhage of blood into small areas of skin
Ecchymosis Blood escapes into large areas of skin
Epistaxis Nosebleed
Hemarthrosis Leakage of blood into joint cavities
Hematemesis Vomiting of blood
Hematoma Swelling or tumor in the tissues or a body cavity that contains clotted blood
Hematuria RBC in urine
Hemoglobinuria Hgb in urine
Melena Stool containing dark red or black blood
Menorrhagia Excessive menstrual bleeding
Vascular Disorders
Hereditary hemorrhagic Most common inherited vascular disorder
telangiectasia Blood vessels are thin & lack smooth muscle
(Oslwer-Weber-Rendu
disease)
Congenital hemangiomata Tumor composed of blood vessels
(Kasabach-Merritt syndrome)
Ehler-Danlos syndrome vascular fragility

Pseudoxanthoma elasticum Elastic fibers are calcified & structurally abnormal

Senile purpura Degradation of collagen & elastin
Scurvy (-) Vitamin C = for collagen synthesis
Defective synthesis of collagen
Henoch-Schonlein purpura Immunologic damage to endothelial cells
Quantitative Platelet Disorders
Thrombocytopenia Platelet production of BM = aplastic anemia
Survival time = platelet destruction (DIC, ITP)
Platelet sequestration by the spleen = splenomegaly
Dilution of platelet count = Thrombo
Units transfused = Thrombocytopenia
Multiple transfusion: stored blood contains nonviable platelets
Thrombocytosis Reactive = moderate increase, asymptomatic (after hemorrhage, splenectomy)
Autonomous = marked increase, associated w/ thrombotic/hemorrhagic
complications (Ex. ET: platelet function is abnormal)
Qualitative Platelet Disorders
Platelet adhesion 1. vWD = (-) vWF
Platelet aggregation test:
= Normal: Epinephrine, Collagen, ADP
= Abnormal: Ristocetin
2. BSS = (-) gpIb
(+) Giant platelets
Platelet aggregation test:
= Normal: Ristocetin
= Abnormal: Epinephrine, Collagen, ADP
3. Storage pool defects

Acquired Uremia: toxic metabolites

Page | 24
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Paraproteinemias: coating of platelet membrane w/ abnormal protein

AML: abnormal megakaryocytes
MPD
Drugs: Aspirin = inhibits COX

Laboratory Tests for Primary Hemostasis

Platelet count 1. Direct (Neubauer counting chamber)
Plt. count/mm3 = # plt x AF x DCF x DF = # plt x 1 x 10 x 200 = # plt x 2,000
(RBC pipette = 1:200 dilution)
1 platelet uncounted = -2,000 plt/mm3
a. Reese-Ecker
- Sodium citrate
- Formaldehyde
- Brilliant cresyl blue
b. Guy and Leake
- Sodium oxalate
- Formaldehyde
- Crystal violet
c. Brecker-Cronkite
- 1% ammonium oxalate (phase contrast microscopy)
------------------------------------------------------------------------------------------------------
d. Unopette
2. Indirect (smear)
Platelet count = (# of plts ÷ 1000 RBC) x RBC count
a. Dameshek

Unopette Diluent: 1% Ammonium oxalate

Stand moist chamber for 15-20mins to allow platelets to settle
1.98mL diluent
0.02mL blood
TV = 2mL
Dilution = 1:100
Plt. count/mm3 = # plt x ACF x DCF x DF = # plt x 1 x 10 x 100 = # plt x 1,000
1 platelet uncounted = -1,000 plt/mm3
Platelet estimate 8-20 platelets/OIO
(Wedge smear) Factor: 20,000
WBC estimate (HPF) Factor: 2,000
Platelet Estimates (Smear)
Platelet Estimate of Report Platelet Estimate as
0- Markedly decreased
50,000- Moderately decreased
100,000- Slightly decreased
150,000- Low normal
200,000- Normal
401,000- Slightly increased
600,000- Moderately increased
Markedly increased

Page | 25
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

N-Plt count, BT Qualitative platelet abnormality

Primary vascular abnormality
vWD
Plt count, N-BT Autoimmune thrombocytopenia
Plt count, BT Simultaneous quantitative and qualitative platelet deficiency
Platelet aggregation test Aggregating agents:
a. Epinephrine
b. Collagen
c. ADP
d. Ristocetin
Sample: Citrated blood Centrifuge at 60-100g for 10mins
PRP + Agonist O.D. monitored (Aggregometer)
Platelet adhesiveness Determination of in vitro platelet adhesion
(Salzmann) Plt ct. 1 = routine collection method
Plt ct. 2 = collected through glass bead collecting system
% PA = [(PC1-PC2) ÷ PC1] x 100
NV = 26-60%
in vWD
Clot retraction time Proportional to platelet count
Clot retraction: function of thrombosthenin
a. Castor oil/Hirschboeck
(+) Dimpling/droplet like serum on the surface of blood drop
NV = 15-45mins
b. Stefanini
c. MacFarlane
CRT = (vol. serum ÷ TV) x 100
NV = 44-67%
Capillary resistance test Measures capillaries to resist pressure
Touriquet test Correlates w/ the degree of thrombocytopenia
Rumpel-Leedes test 100 mmHg for 5 mins After 15-30mins, count petechiae
(or halfway bet. systolic & diastolic pressure for 5 mins)
+1 = 0-10 petechiae (few)
+2 = 10-20 petechiae (many)
+3 = 20-50 petechiae (multiple)
+4 = >50 petechiae (confluent)
NV = 0 to occasional
Not repeated on the same arm for 7 days
Bleeding time In vivo measure of primary hemostasis
a. Duke method = fingertip/earlobe
b. Ivy method = uses blood pressure cuff (40mmHg) puncture forearm
Secondary Hemostasis
Coagulation factors All are produced in the liver except Factor VIII
In liver disease, all coagulation factors are except factor VIII complex
Factor VIII complex:
a. VIII: Coagulant (VIII:C)
b. vWF: produced by megakaryocytes and endothelial cells
Activated at cold temp. = VII & XI
Coagulation Factors
Numeral Preferred Name Synonyms
I Fibrinogen

Page | 26
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

II Prothrombin Prethrombin
III Tissue factor Tissue thromboplastin
IV Calcium
V Proaccelerin Labile factor
Accelerator globulin (aCg)
VII Proconvertin Stable factor
Serum prothrombin conversion
accelerator (SPCA)
VIII:C Antihemophilic factor Antihemophilic factor globulin (AHG)
Antihemophilic factor A
Platelet cofactor 1
IX Plasma thromboplastin component Christmas factor
Antihemophilic factor B
Platelet cofactor 2
X Stuart-Prower factor Stuart factor
Prower factor
Autoprothrombin III
XI Plasma thromboplastin component Antihemophilic factor C
XII Hageman factor Glass factor
Contact factor
XIII Fibrin stabilizing factor Laki-Lorand factor
Fibrinase
Plasma transglutaminase
Fibrinoligase
- Prekallikrein Fletcher factor
- High-molecular weight kininogen Fitzgerald factor
Contact activation cofactor
Williams factor
Flaujeac factor
Stage I: Generation of Intrinsic: XIIXIIX VIII (Cofactor)
Thromboplastin Extrinsic: IIIVII
Common: X V (Cofactor)
----> Common thromboplastin/Prothrombinase (Va-Xa-Ca2+-PL)
Stage II: Conversion of II ---(Prothrombinase)---> Thrombin
prothrombin to thrombin
Stage III: Conversion of I ---(Thrombin)---> Fibrin clot
fibrinogen to fibrin clot XIII---(Thrombin)---> XIIIa
Fibrin clot ---(XIIIa)---> Stable fibrin clot
Fibrinogen Most concentrated
Calcium Involved in all stages of coagulation except contact phase
Contact group XII, XI, PK, HMWK
Ca2+ independent
Vit. K independent
Involved in the contact phase
XII ---(Collagen)---> XIIa (small amount)
PK ---(XIIa)--------> Kallikrein
XII ---(Kallikrein+HMWK)---> XIIa (large amount)
XI ---(XIIa)---------> XIa
Fibrinogen group I, V, VIII, XIII
Ca2+ dependent
Page | 27
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Vit. K independent
Completely consumed during coagulation
(+) in plasma
(-) in serum
Prothrombin group II, VII, IX, X
Ca2+ and Vit. K dependent
First: VII IX X II: Last
Adsorbable factors: removed by adsorbing agents [BaSO4, Al(OH)3]
(+) in plasma
(-) in serum
Diseases BT PT APTT Stypven TT
N N N N N
Fibrinogen deficiency N* N
Prothrombin deficiency N N N
Parahemophilia N N N
Factor VII deficiency N N N N N
Hemophilia A N N N N N
von Willebrand disease N N N N
Hemophilia B N N N N N
Factor X deficiency N N N
Hemophilia C N N N N N
Factor XII deficiency N N N N N
Factor XIII deficiency N N N N N Abn
DIC Abn
*BT may be prolonged in afibrinogenemia
Fresh Plasma Aged Plasma Adsorbed Plasma Fresh Serum Aged Serum
I + + + - -
II + + - + (<20%) -
V + - + - -
VII + + - + +
VIII + - + - -
IX + + - + +
X + + - + +
XI + + + + +
XII + + + + +
XIII + + + - -
Prothrombin:
80% is consumed during coagulation
<20% residual prothrombin
Disorders of Coagulation Causing Clotting Factor Deficiencies
Inherited Coagulopathies Acquired Coagulopathy
Factor
Inheritance Pattern Coagulopathy
I Autosomal recessive Afibrinogenemia Liver disease
Autosomal dominant Dysfibrinogenemia DIC
Fibrinolysis
II Autosomal recessive Prothrombin deficiency Liver disease
Vit. K deficiency
Anticoagulant therapy
V Autosomal recessive Liver disease
Labile factor deficiency DIC
Page | 28
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Parahemophilia Fibrinolysis
VII Autosomal recessive Factor VII deficiency Liver disease
Vit. K deficiency
Anticoagulant therapy
VIII X-linked recessive Hemophilia A DIC
Autosomal dominant vWD Fibrinolysis
IX Autosomal recessive Hemophilia B Liver disease
Christmas disease Vit. K deficiency
Anticoagulant therapy
X Autosomal recessive Factor X deficiency Liver disease
Vit. K deficiency
Anticoagulant therapy
XI Autosomal recessive Hemophilia C Unclear
Rosenthal syndrome
=Common in Jewish descent/
Ashkenazi Jews
XII Autosomal recessive Factor XII deficiency Unclear
=No bleeding tendency
XIII Autosomal recessive Factor XIII deficiency Liver disease
DIC
Fibrinolysis
PK Autosomal recessive Fletcher trait Unclear
HMWK Autosomal recessive Fitzgerald trait Unclear
Factor VIII deficiency Common inherited coagulation factor deficiency

b. vWD = most frequently inherited coagulation disorder

Major sites of coagulation Endothelium
inhibition Platelet
Protein C Degrades factor Va and VIIIa
Protein S Vit. K dependent glycoprotein
Antithrombin Major inhibitor of thrombin
Tests for Secondary Hemostasis
Clotting time Measure the period required for free form of blood to clot after it has been
removed from the body
a. Capillary blood method
= Drop or slide
= Capillary tube/Dale and Laidlaw
= Blue capillary tube
NV = 2-4mins
b. Whole blood/Lee and White
NV = 7-15mins
Prothrombin time Detect coagulation factor deficiencies involving extrinsic and common pathway
Citrated blood Centrifuge at 2000g for 10mins PPP
PPP + Thromboplastin-CaCl2 rgt (+) Clot
Begin timing for clot formation on the addition of CaCl2 rgt
NV = 10-12 secs
Activated partial Detect coagulation factor deficiencies involving intrinsic and common pathway
thromboplastin time PPP + APTT rgt:
1. Activators:
a. Micronized silica

Page | 29
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

b. Ellagic acid
c. Celite
d. Kaolin
2. Phospholipids: substitute for platelets
3. CaCl2
Begin timing for clot formation on the addition of CaCl2 rgt
NV = 25-35 secs
Stypven time/Russel viper East Indian viper venom Vipera russelli: directly activates factor X
venom time Detect coagulation factor deficiencies involving common pathway
PPP + Stypven rgt: platelin-CaCl2 rgt
NV = 6-10 secs

Thrombin time Prolonged in:

a. Fibrinogen deficiency
b. Presence of FDP or FSP
c. Presence of thrombolytic agent (Ex. streptokinase)
d. Presence of heparin
PPP + Thrombin-CaCl2 rgt
NV = 10-14 secs
Reptilase time Enzyme found in the venom of Bothrops atrox snake
Prolonged in:
a. Fibrinogen deficiency
b. Presence of FDP or FSP
c. Presence of thrombolytic agent
Not affected by heparin
PPP + Atroxin
Begin timing for clot formation upon the addition of atroxin
NV = 10-15 secs
For factor XIII deficiency
5M urea solubility test Rgt: 5M Urea
Substitutes for urea:
- 1% monochloroacetic acid
- 2% acetic acid
Normal = Clot is insoluble to urea (24 hrs)
F. XIII def. = Clot is soluble to urea (24 hrs)
Circulating anticoagulants Prolonged APTT and PT not corrected
Lupus inhibitor Against the phospholipid portion of prothrombinase complex (Va-Xa-Ca2+-PL)
Instrumentation for Tests of Hemostasis
Tilt tube method Visual detection of fibrin clot formation
Manual technique
End point = clot formation
Fibrometer Electromechanical detection of fibrin clot formation
Fibrin strand formation is detected using a wire loop or hook w/c has been
incorporated into a semi-automated mechanical instrument
Photo-optical detection of Detection of fibrin clot formation depends on in light scattering associated w/
clot formation conversion of fibrinogen fibrin
Semi-automated instruments:
- Electra 750 and 750A
- Fibrintimer series
- FP 910 coagulation analyzer

Page | 30
Downloaded by Sheena Blones (shinafied@gmail.com)

Fibrinolysis
Plasminogen activators
Inhibitors of fibrinolysis
Degradation of cross-linked
fibrin by plasmin
Degradation of non-
crosslinked fibrin and
fibrinogen by plasmin
Primary fibrinolysis
Secondary fibrinolysis
lOMoARcPSD|30126890
Automated instruments:
- Ortho Koagulab 16S and 40A
- Coag-A-Mate X2 and XC
- MLA Electra 700 and 800
Digestion of fibrin clot
Occurs when plasminogen plasmin
1. Intrinsic activators
- XIIa
- Kallikrein
- HMWK
2. Tissue type
- Urokinase-like PA
3. Therapeutic activators = treatment for thromboemboli
- Streptokinase
- Urokinase
- Tissue-like PA
2-antiplasmin = Major inhibitor
2-macroglobulin
Thrombospondin
PA inhibitor 1 and 2
Crosslinked fibrin (urea insoluble)
(Plasmin)
Complex DD/E | Complex YD/DY | Complex YY/DXD
(D-dimer)
Fibrinogen or
Noncrosslinked fibrin (urea soluble)
(Plasmin)
Fragment X
(Plasmin)
Fragment Y | Fragment D
(Plasmin)
Fragment D | Fragment D
No fibrin monomer
No fibrin polymer
No D-dimer
Plasminogen activators from damaged/malignant cells
Converts plasminogen plasmin in the absence of fibrin formation
Prostatic carcinoma
DIC = uncontrolled, inappropriate formation of fibrin w/in the blood vessels
w/ fibrin monomer
w/ fibrin polymer
w/ D-dimer = most specific for DIC
Infection: N. meningitidis
Page | 31
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Neoplasm
Snake bite
HTR
Laboratory Evaluation of Fibrinolysis
Whole blood clot lysis time
(WBCLT) Clot lysis prior to 48 hrs indicates excessive systemic fibrinolysis
Euglobulin lysis time Euglobulins: proteins that ppt. when plasma is diluted w/ H2O & acidified
- Plasminogen
- Plasmin
- Fibrinogen
- Plasminogen activators
Plasma + Acetic acid Ppt. euglobulin
Euglobulin + thrombin Clot euglobulin
Euglobulin Dissolved in buffer
Normal = No clot lysis (2 hrs)
Fibrinolysis = Clot lysis <2 hrs
Protamine sulfate test -DIC) in the plasma
Plasma + Protamine sulfate + ETOH (+) gel-like clot (paracoagulation)
Ethanol gelation test -DIC) in the plasma
Plasma + NaOH (pH) + ETOH (+) pptn/gel
Latex D-dimer assay Most specific test for DIC
Test Primary Fibrinolysis Secondary Fibrinolysis
WBCLT < 48 hrs < 48 hrs
Euglobulin clot lysis < 2 hrs < 2 hrs
Ethanol gelation - +
Protamine sulfate - +
D-dimer - +
Heparin Injected
Action: inhibits thrombin
Monitoring: APTT = sensitive, method of choice (CAP)
Neutralize w/ protamine sulfate
Warfarin Oral
Coumarin WARF: Wisconsin Alumni Research Foundation
Coumadin Action: Vit. K antagonist, inhibits II, VII, IX, X
Monitoring: PT (reported in INR)
Neutralize w/ Vitamin K, FFP
INR International normalized ratio
INR = (Patient PT ÷ Normal PT)ISI
INR = 2-3
- Prevents MI, embolism & thrombosis
INR = 2.5-3.5
- For patients w/ mechanical heart valves
ISI International Sensitivity Index (PT rgt)
PT rgt is calibrated w/ Manchester rgt = from human brain thromboplastin

Page | 32
Downloaded by Sheena Blones (shinafied@gmail.com)

Brightfield microscopy
Oil immersion microscopy
Phase-contrast microscopy
Fluorescence microscopy
Electron microscopy
Basic component of Standard
light microscope
Total magnification
Hemoglobin
Acid hematin
Alkali hematin
Gasometric (Van Slyke)
Chemical
SG method
Cyanmethemoglobin/
Hemiglobincyanide method
lOMoARcPSD|30126890
HEMATOLOGY PROCEDURES
Examine blood films
Erythrocyte morphology & leukocyte differential
For manual platelet counts
ANA and T/B cell studies
Observation of fine ultrastructures of cells (100,000x magnification)
Diopter rings: adjust for focusing differences between eyes
Rubber eyeguard: adjust for comfort
Eyepiece tube clamp screw: loosen to rotate head
Reverse facing nosepiece: for ease in specimen manipulation
Revolving nosepiece: use to rotate objectives
Objectives: lenses w/c form primary image of specimen
Field diaphragm: aperture diaphragm w/c restricts area of illumination
Field diaphragm control ring: adjust size opening of field diaphragm
Coarse focus knob: brings slide into view
Fine focus knob: sharpens image
Lamp socket: holds light source
Interpupillary distance scale: indicates distance between eyes
Eyepiece: magnify image formed by objective lens
Stage: holds specimen
Slide holder: holds slide in place
Condenser control ring: adjusts size opening of condenser
Condenser: aperture diaphragm that controls light
Condenser centering screws: center the field of view
Condenser focus know: focuses light onto slide
X/Y travel knobs: moves slides on stage
Brightness control dial: turns microscope on/off, adjusts light intensity
TM = Ocular x Objective
(10)(LPO: 10) = 100x
(10)(HPO: 40) = 400x
(10)(OIO: 100) = 1,000x
Hemoglobin Determination
AM, PM
Strenuous muscular activity
Altitude = Hgb
Lying down
Rgt: 0.1N HCl
Comparing the brownish yellow color of solution to standard comparator block
Rgt: 0.1N NaOH
Not for newborns (HbF: alkali resistant)
1g Hgb = 1.34mL O2
1g Hgb = 3.47mg Fe2+
CuSO4 method (See BB notes)
Manual and automated
Dilution = 0.02mL blood: 5mL rgt (1:251)
Reagents:
a. Potassium ferricyanide = ferrous ferric
Page | 33
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

b. Potassium cyanide = Hi HiCN

c. Nonionic detergent = lysis of red cells, decreases turbidity

*Color intensity is measured at 540nm

*All forms of Hgb are measured except SulfHb
*Overanticoagulation does not affect result
Turbidity = False
a. High WBC count: to correct, centrifuge read supernatant
b. HbS & HbC: to correct, dilute 1:1 w/ H2O result x 2

Rule of three 3 x RBC = Hgb

3 x Hgb = Hct
Apply only to normocytic, normochromic red cells
Hematocrit Determination
Macromethods Large volume of blood
1. Wintrobe & Landsberg = Double oxalate
2. Van Allen = Sodium oxalate
3. Haden = Sodium oxalate
4. Sanford-Magath = Sodium oxalate
5. Bray = Heparin
Centrifuge: 2000-2300g for 30mins
Layers (Spun Hct):
1st: Fatty layer = barely visible unless the patient is lipemic
2nd: Plasma
3rd: Buffy coat (1mm = 10,000 WBCs/mm3)
Bottom: Packed cells
Wintrobe tube Length = 11.5cm
Bore = 3.0mm
Calibration = 0-100
a. Left: 0-100 (ESR)
b. Right: 100-0 (Hct)
Micromethod (Adam) Capillary tube:
Length = 7.0-7.5cm (70-75mm)
Bore = 1mm
Anticoagulant: Red (Heparin)
No anticoagulant: Blue
Centrifuge: 10,000-15,000g for 5mins
Trapped plasma: plasma that remains in RBC portion after spinning
= in poikilocytosis
Advantages:
a. Better packing of cells
b. Less blood
c. Less time consumed
Layers:
Top: Plasma
2nd: Platelets
3rd: Leukocytes
4th: Retics & nRBCs
5th: Mature RBCs
Bottom: Clayseal (4-6mm)
Page | 34
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Automated methods Hct = only computed

Hct = MCV x RBC count

RBC Count
RBCs AM, PM
RBC diluting fluids Isotonic solutions
1.) NSS
2.) 3.8% Sodium citrate
3.) Dacies or formol citrate
4.)

7.)
Dilution (RBC pipette) = 0.5:100 (Blood: Diluent) = 1:200
RBC count RBC/mm3 = # RBC x AF x DCF x DF = # RBC x 5 x 10 x 200 = # RBC x 10,000
WBC Count
WBCs AM, PM
WBC Diluting fluids Hypotonic solutions: lyse non-nucleated RBCs
1.) 1-3% acetic acid
2.) 1% HCl
2O
Mix = 3 mins (To allow lysis of RBCs)
Dilution (WBC pipette) = 0.5:10 (Blood: Diluent) = 1:20
Leukocytosis = Use RBC pipette (1:100 or 1:200)
WBC count WBC/mm3 = # WBC x AF x DCF x DF
Counting Chamber
2 counting areas
Each CA w/ 16 1mm2 squares
Depth = 0.2mm
Depth factor = 5
Volume = Area x Depth x # CA = 16mm2 x 0.2mm x 2 = 6.4mm3
Volume/counting chamber = 3.2mm3
4 counting areas
Each CA w/ 10 1mm2 squares
Depth = 0.2mm
Depth factor = 5
Volume = Area x Depth x # CA = 10mm2 x 0.2mm x 4 = 8mm3
Volume/counting chamber = 2mm3
Improved Neubauer 2 primary squares
2

Depth = 0.1mm
Depth factor = 10
Volume = Area x Depth x # CA = 9mm2 x 0.1mm x 2 = 1.8mm3
Volume/counting chamber = 0.9mm3
RBC count Center square:

Each
25 x 16 = 400
5 (counted) x 16 = 80 small squares
WBC count 4 corners:

Page | 35
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Nucleated RBCs Not lysed by WBC diluents

Falsely counted as WBCs

NV:
differential

Formula for WBC correction Corrected WBC = uncorrected WBCs x 100

100 + NRBCs
Preparation and Staining Procedures for the Blood Smear
Techniques 1. Cover glass smear (Ehrlich)
2. Cover glass and slide (Beacom)
3. Wedge smear/Push/Spreader slide technique

250 (30-400) Angle between 2 slides

22 x 22mm Square coverslip
2-3mm Drop of blood
0.25 inch (1cm) Distance of blood drop from the frosted edge of the slide
0.5 inch Smear terminates near the end of the slide (automated spreader)
Buffy coat smear For patients w/ WBC count of <1 x 109/L
Demonstration of LE cell
Thick blood smear For blood parasites
Methanol Fixative for blood and BM smears
Toxic, causes permanent blindness

Giemsa = preferred stain for blood parasites

w/in 2-3 hours of specimen
collection
pH 6.8
pH 7.2
Excessively blue stain
Excessively pink stain
Cross-sectional or
-Giemsa
Leishman
Jenner
May-Grunwald
------------------------------------------------------------------------------------------------------
Contains:
= Methylene blue (or Azure B - oxidized): basic
= Eosin: acidic
Time blood smears should be stained
Blood and bone marrow staining
Malarial parasite staining
Thick films
Prolonged staining time
Inadequate washing
Too high alkalinity of stain
Diluents tends to cause excessive basophilia
Insufficient staining
Prolonged washing time
Mounting coverslips before they are dry
Too high acidity of the stain
Buffer may cause excessive acidophilia
Blood film is moved from side to side
Page | 36
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

crenellation method
Longitudinal method WBCs are counted from the tail toward the head of the smear
Battlement method Near the tail on a horizontal edge: count 3 consecutive horizontal edge fields, count
2 fields towards the center of the smear, count 2 fields horizontally, count 2 fields
vertically to the edge
WBC Counting 100 cells = routine
50 cells = if patient WBC count <1.0 x 109/L
200 cells:
= >10% eosinophils
= >2% basophils
= >11% monocytes
= lymphocytes > neutrophils (except in children)
PV patients Thinner smear:
- smaller blood drop
- slow spread
- low angle
Anemic patients Thicker smear:
- larger blood drop
- fast spread
- increase angle
Neutrophils Relative = 47-77%
Absolute = 1.8-7.8 x 109/L
Lymphocytes Relative = 20-40%
Absolute = 1.0-4.8 x 109/L
Monocytes Relative = 2-10%
Absolute = 0.01-0.8 x 109/L
Eosinophils Relative = 0-6%
Absolute = 0-0.6 x 109/L
Basophils Relative = 0-1%
Absolute = 0-0.2 x 109/L
Neutrophilia Appendicitis
Myelogenous leukemia
Bacterial infections
Eosinophilia Allergies
Scarlet fever
Parasitic infections (T. spiralis)
Eosinophilic leukemia
Lymphocytosis Viral infections
Whooping cough
IM
Lymphocytic leukemia
Lymphoma
Monocytosis Brucellosis
Tuberculosis
Monocytic leukemia
SBE
Typhoid
Rickettsial infections
Collagen disease

Page | 37
Downloaded by Sheena Blones (shinafied@gmail.com)

Shift to the left
Shift to the right
Reticulocyte count
% Retics
Absolute reticulocyte count
Corrected reticulocyte count
Reticulocyte production
index/Shift correction
Maturation time of retics in
the blood
RPI > 3
RPI < 2
Miller disk
Eosinophil count
Eosinophilia
Eosinopenia
Eosinophil diluting fluids
lOMoARcPSD|30126890
(+) immature granulocytic cells
Leukemia
Bacterial infections
NV:
Adult = 0.5-1.5% (Ave: 1.0%)
Newborn = 2-6%
[# Retics ÷ # RBC (1000)] x 100
ARC = (% Retics ÷ 100) x RBC count (1012/L) x 1,000
NV = 25-75 x 109/L
CRC = % Retics x (Patient Hct ÷ Normal Hct [0.45L/L])
NV = 1
General indicator of the rate of erythrocyte production increase above normal in
anemias
Indicates BM response to anemia
RPI = CRC ÷ Maturation time of retics in the blood
NV = 1 (Hct: 45%)
1.0 day = Hct: 45 ± 5%
1.5 days = Hct: 35 ± 5%
2.0 days = Hct: 25 ± 5%
2.5 days = Hct: 15 ± 5%
Adequate response of BM to anemia
- Chronic hemolysis
- Recent hemorrhage
- Response to therapy
Inadequate response of BM to anemia
- Aplastic anemia
- Ineffective erythropoiesis (megaloblastic anemia)
% Retics = Retics (A) ÷ [RBC (B) x 9] x 100
NV = 50-350 x 106/L
Allergic reactions
Parasitic infections
Brucellosis
Leukemias
Shock
Administration of ACTH
Composition:
a. Phloxine/eosin/neutral red iodide = stains eosinophils
b. Propylene glycol = lyses RBCs
c. Na2CO3 = lyses WBCs except eosinophils, intensifies staining of granules
d. Heparin = prevents clumping
Diluting fluids:
4. Hinkleman = eosin
Page | 38
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Assess adrenocortical function

Sample 1: fasting specimen
Sample 2: 4 hrs after administration of ACTH ( eo. count)
Normal: Eo. count: 1 > 2 (lower by 50%)
Abnormal: Eo. count: 1 = 2 (hypoadrenalism)
Erythrocyte Indices (Wintrobe Indices)
RBC indices Classify anemia according to RBC morphology
MCV MCV = (Hct ÷ RBC) x 10
3
NV = 80- )
MCH MCH = (Hgb ÷ RBC) x 10
NV = 27-
Rarely used
MCHC MCHC = (Hgb ÷ Hct) x 100
NV = 31-36% (31-36 g/dL)
Defective centrifuge Values affected:
= Hct
= MCV
= MCHC
MCHC >38% does not occur Incorrect calculation
(+) cold agglutinins
MCHC will not fall <22% Lipemia
(+) HbS & HbC
Erythrocyte Sedimentation Rate (ESR)
ESR Nonspecific measurement used to detect & monitor an inflammatory response to
tissue injury
ESR Erythrocytes:
*Macrocytes
*Anemia
Plasma composition: most important determinant
*Fibrinogen
1-globulin
2-globulin
-globulin
-globulin
*Cholesterol
Technical factor:
*Tilting = 30 angle = 30% error
* Temp.
ESR Erythrocytes:
*Microcytes
*Poikilocytes
*Polycythemia
*Anisocytes
Plasma factor: most important determinant
*Albumin
*Lecithin
Technical factor:
*Overanticoagulation = EDTA = shrinkage of RBC = Hct, ESR
Stages of ESR 10 mins = 1. Initial rouleaux
40 mins = 2. Rapid settling of RBCs

Page | 39
Downloaded by Sheena Blones (shinafied@gmail.com)

Wintrobe & Landsberg
Standard/Original
Westergren
Modified Westergren
Zeta Sedimentation Ratio
(ZSR)
Erythrocyte Osmotic Fragility
test
(Griffin and Sanford method)
Ascorbate cyanide screening
G6PD fluorescent screening
Paroxysmal nocturnal
hemoglobinuria (PNH)
Sucrose hemolysis test
Patient has received normal
RBCs
lOMoARcPSD|30126890
10 mins = 3. Final sedimentation of RBCs
60 mins = Total
Requires smaller amount of blood
Involves no dilution
Length: 11.5cm (115mm)
Internal bore: 3.0mm
Anticoagulant: Double oxalate
Most sensitive
Requires more blood
Length: 300mm
Internal bore: 2.65 ± 0.15mm
Anticoagulant: Citrate (black)
Anticoagulant-to-Blood ratio = 1:4
Anticoagulant: 2mL EDTA + 0.5mL NSS/Citrate
Not affected by anemia
Major disadvantage: requires special capillary tubes and Zetafuge
ZSR = (%Hct ÷ %Zetacrit) x 100
Anticoagulant: Heparin
% NaCl = # drops NaCl x 0.02
Add RBCs, stand for 2hrs at room temp
Check for hemolysis (pink/red supernatant)
NV:
- Initial hemolysis = tube 21 or 22 (0.42-0.44%)
- Complete hemolysis = tube 16 or 17 (0.32-0.34%)
Detects deficiencies in the pentose phosphate pathway:
- G6PD
- glutathione peroxidase
- glutathione reductase
Rgts:
- Na ascorbate
- Na cyanide
Normal = red
(-) Enzyme = brown
G6P + NADP ---(RBC: G6PD)---> 6-phosphogluconate + NADPH (fluorescence)
Normal: Max fluorescence at 10mins
G6PD def: Little or no fluorescence
Acquired disorder in w/c red cells are abnormally sensitive to complement
(-) DAF
Screening test for PNH
Patient RBCs + ABO compatible serum + sucrose solution
Normal = (-) Hemolysis
PNH = (+) Hemolysis
Confirmatory test for PNH
Tube 1: Patient RBCs + normal serum + weak acid (0.2N HCl)
Tube 2: Patient RBCs + patient serum + weak acid (0.2N HCl)
Tube 3: Patient RBCs + normal inactivated serum + weak acid (0.2N HCl)
Normal = (-) Hemolysis on all tubes
PNH = (+) Hemolysis except on Tube 3 (inactivated serum)
Patient w/ PNH + blood transfusion --- ---> Hemolysis
Page | 40
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

PCH IgG autoanti-P = biphasic hemolysin

- Cold = attaches to RBCs
- Warm = RBC lysis
Donath-Landsteiner test Test for PCH

Normal = (-) hemolysis on test and control

PCH = (-) hemolysis on control but (+) hemolysis on test sample
Autohemolysis test Blood alone ---(48 hrs)---> Hemolysis: >0.2 to 2%
Blood + glucose ---> Hemolysis: 0-0.8%
Blood + ADP ---> Hemolysis: 0-0.9%
------------------------------------------------------------------------------------------------------
G6PD deficiency (PPP) = corrects w/ glucose only
PK deficiency (EMP) = corrects w/ ADP only
H. Spherocytosis = corrects w/ ADP and glucose
Potential Causes of Erroneous Results with Automated Cell Counters
Parameter Causes of Spurious Increase Causes of Spurious Decrease
WBC count Cryoglobulin Clotting
Cryofibrinogen Smudge cells
Heparin Uremia plus immunosuppressants
Monoclonal proteins
Nucleated RBCs
Platelet clumping
Unlysed RBCs
Platelet count Cryoglobulin Clotting
Cryofibrinogen Giant platelets
Hemolysis Heparin
Microcytic RBCs Platelet clumping
RBC inclusions Platelet satellitism
WBC fragments
RBC count Cryoglobulin Autoagglutination
Cryofibrinogen Clotting
Giant platelets Hemolysis
WBC > Microcytic RBCs
Hemoglobin HbCO >10% Clotting
Cryoglobulin Sulfhemoglobin
Cryofibrinogen
Hemolysis
Heparin

Hyperbilirubinemia
Lipemia
Monoclonal proteins
Hematocrit (automated) Cryoglobulin Autoagglutination
Cryofibrinogen Clotting
Giant platelets Hemolysis
Microcytic RBCs
Hyperglycemia >600mg/dL
Hematocrit (microhct) Hyponatremia Excess EDTA
Plasma trapping Hemolysis

Page | 41
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

Hypernatremia
MCV Autoagglutination Cryoglobulin
Cryofibrinogen
Hyperglycemia Giant platelets
Reduced red cell deformability Hemolysis
Microcytic RBCs
Swollen RBCs
MCHC Autoagglutination
Clotting Spuriously low Hgb
Hemolysis Spuriously high Hct
Spuriously high Hgb
Spuriously low Hct
Cryoglobulin Increased: WBC count, RBC count, Platelet count, Hgb, Hct
Cryofibrinogen Decreased: MCV
Heparin Increased: WBC count, Hgb
Decreased: Platelet count

Clotting Increased: MCHC

Decreased: WBC count, RBC count, Platelet count, Hgb, Hct
Hemolysis Increased: Hgb, MCHC, Platelet count
Decreased: RBC count, Hct, MCV
Autoagglutination Increased: MCV, MCHC
Decreased: RBC count, Hct
Defibrinated blood Blood Glass Beads/clips

- OFT
- Autohemolysis test
- Acidified serum test
Automated Cell Counter
Optical light scattering Blood cells when subject to light will create forward & side light scatters w/c are
detected by photodetector
Forward LS = cell size
Side LS/900/right angle scatter = cell granularity
Ex. Technicon autoanalyzer
Electrical impedance Blood cells are nonconductors of electricity. they create impedance or resistance of
current when passed in a solution that conduct electricity
Ex. Sysmex counter, Coulter counter
Coulter counter Triplicate count (3x)
a. Blood is diluted 1:6250 (isotonic)
RBCs = 36-360fL
Plts = 2-20fL
b. Blood is diluted 1:251 (hypotonic)
Lymphocytes = 35-90fL
Monocytes = 90-160fL
Granulocytes = 160-450fL
Histograms RBCs, WBCs, plts
X-axis
- Horizontal/abscissa
- Size of cells
Y-axis

Page | 42
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

- Vertical/ordinate
- Number of cells
V=IxR
Where:
V = voltage
I = current
R = resistance
Positive error
Bubbles
Extraneous electrical pulses
Aperture plug
Negative error Count
Improper setting of aperture error
Polychromasia grading % of RBCs that are polychromatophilic
Slight = 1%
1+ = 3%
2+ = 5%
3+ = 10%
4+ = >11%
Normocytic, Normochromic 1. Defective formation of RBCs or the presence of tumor cells in BM:
RBCs *Aplastic anemia
*Leukemia

*Multiple myeloma
*Leukoerythroblastosis
*Metastatic cancer
*Anemia of renal & endocrine disease
*Anemia of inflammatory disease
2. Abnormal hemoglobin, increased destruction of RBCs
*Certain acquired hemolytic anemia
*PNH
*Sickle cell anemia
*HDN
*Anemia of chronic renal insufficiency
Hemolytic anemias 1. Intrinsic defects w/in RBC
a. Hereditary membrane defects
**Spherocytosis
**Elliptocytosis
**Acanthocytosis
**Stomatocytosis
**Rh null disease
b. Hereditary enzyme defects
**G6PD
**PK
c. Hereditary hemoglobinopathies
**Sickle cell disease
**Hemoglobin C disease
d. Unstable hemoglobin disease
**Hemoglobin E disease
e. Hereditary defective globin synthesis
**Thalassemia
Page | 43
Downloaded by Sheena Blones (shinafied@gmail.com)
 lOMoARcPSD|30126890

f. Acquired
**PNH
2. Extracorpuscular causes: nonimmune acquired hemolytic anemias
*Chemicals, toxins, venoms
*Physical trauma: disorders causing fragmentation (burns, cardiac replacement
valves, MAHA, HUS)
3. Extracorpuscular causes: immune hemolytic anemias
*Isoimmune antibodies: incompatible blood transfusion, HDN
*Autoimmune antibodies: warm/cold reacting, drug-induced
4. Miscellaneous
*Anemia of liver disease
*Sulfhemoglobinemia
*Porphyrias
*Methemoglobinemias

Page | 44
Downloaded by Sheena Blones (shinafied@gmail.com)